Valencia-Nieto, Laura http://orcid.org/0000-0003-3992-991X
Pinto-Fraga, José http://orcid.org/0000-0001-8179-9253
Blanco-Vázquez, Marta http://orcid.org/0000-0001-7054-3287
Fernández, Itziar http://orcid.org/0000-0002-5077-4448
López-Miguel, Alberto http://orcid.org/0000-0001-9429-1571
García-Vázquez, Carmen http://orcid.org/0000-0002-9281-6255
González-García, María J. http://orcid.org/0000-0003-3673-0585
Enríquez-de-Salamanca, Amalia http://orcid.org/0000-0003-1274-7796
Calonge, Margarita http://orcid.org/0000-0001-8178-4836
Clinical trials referenced in this document:
Documents that mention this clinical trial
Short-Term Efficacy of Ophthalmic Cyclosporine: A 0.1% Cationic Emulsion in Dry Eye Patients Assessed Under Controlled Environment
https://doi.org/10.1007/s40123-024-00906-1
Funding for this research was provided by:
Santen (Investigator-initiated study grant)
Article History
Received: 11 January 2024
Accepted: 5 February 2024
First Online: 6 March 2024
Declarations
:
: No conflicting relationship exists for any author. Disclosures of Dr. Margarita Calonge are the following: Research/clinical trials contracts, consultantships,advisory boards and/or lectures for Novartis, Santen Pharmaceutical, Johnson & Johnson, Horus Pharma, Fidia Farmaceutica, UrsaPharm GmbH, and Thea Laboratories. Alberto Lopez Miguel is an Editorial Board member of Ophthalmology and Therapy. Alberto Lopez Miguel was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. The remaining authors have no relationship to disclose.
: The Ethics Committee of the Valladolid University Clinical Hospital (Valladolid, Spain) and the Spanish Drugs and Health Products Administration (ExternalRef removed) (EudraCT number: 2019-000982-19) approved the trial. It was registered at the US National Institutes of Health (ClinicalTrials.gov, ID: NCT04492878). It was conducted at the Institute of Applied Ophthalmobiology, University of Valladolid, Valladolid, Spain. The study followed the tenets of the Declaration of Helsinki and the Good Clinical Practices.